ThirtyFiveBio
Biotechnology Research
Milton, Kent, United Kingdom
15 employees
- Employees
- 15
- Contacts
- 2
- Emails
- 2
ThirtyFiveBio Overview
- Headquarters
- Milton, Kent, United Kingdom
- Website
- 30fivebio.com
- Industry
- Biotechnology Research
- Employees
- 15
- Funding
- 196
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About ThirtyFiveBio
Founded by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs based in Oxford, UK, the company is founded upon a deep understanding of the human biology of GPR35. We are developing small-molecule inhibitors for the treatment of ulcerative colitis and other GI diseases.
ThirtyFiveBio Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
ThirtyFiveBio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Helen Carlile | Director of Operations at Thirtyfivebio | Greater Reading Area, United Kingdom |
Email
|
| Stuart Hughes | CEO at Nuage Therapeutics | Greater Oxford Area, United Kingdom |
Email
|
| Lisa Shoesmith | Director of Finance @ Mtm - Pathios |
View
|
|
| Peter Joyce | CEO and Co-founder Greywolf Therapeutics |
View
|
Employees by Management Level
Executive
2 profiles
Director
2 profiles
Compare Similar Companies to ThirtyFiveBio
Sygnature Discovery
Biotechnology Research
Enara Bio
Biotechnology
Greywolf Therapeutics
Biotechnology Research
Molecule to Medicine
Biotechnology Research
Theolytics
Biotechnology Research
Nuage Therapeutics
Biotechnology Research
Pathios Therapeutics
Biotechnology Research
Outrun Therapeutics
Biotechnology Research
Lucia Bio
Biotechnology Research
Melio Bio
Biotechnology Research